Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
Fecha
2016-02
Título de la revista
ISSN de la revista
Título del volumen
Editor
Springer
Resumen
Palabras clave
Angiogenesis , Biomarkers , Cyclophosphamide , Celecoxib , Metronomic chemotherapy